These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4561711)

  • 1. [Direct positive inotropic cardiac effect of aldactone (spironolactone, canrenoate-K)].
    Schröder R; Ramdohr B; Hüttemann U; Schüren KP
    Dtsch Med Wochenschr; 1972 Oct; 97(41):1535-8. PubMed ID: 4561711
    [No Abstract]   [Full Text] [Related]  

  • 2. [Aldactone (spironolactone, canrenoate-K) in the treatment of chronic cor pulmonale].
    Hüttemann U; Schüren KP
    Dtsch Med Wochenschr; 1972 Oct; 97(41):1533-5. PubMed ID: 5075792
    [No Abstract]   [Full Text] [Related]  

  • 3. [Direct positive inotropic influencing on the heart using oral spironolactone therapy].
    Schröder R; Ramdohr B; Hüttemann U; von Leitner E; Schüren KP
    Verh Dtsch Ges Kreislaufforsch; 1972; 38():349-53. PubMed ID: 4576732
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention and abolition of ouabain-induced ventricular tachycardia by potassium canrenoate in dogs.
    Yeh BK; Sung PK
    Eur J Pharmacol; 1972 Aug; 19(2):151-5. PubMed ID: 5071786
    [No Abstract]   [Full Text] [Related]  

  • 5. [Heart failure therapy with digitalis and spironolactone--studies within the scope of preoperative treatment before lung resection].
    Daum S; Goerg R; Mack D; Wang D
    Prax Klin Pneumol; 1984 Sep; 38(9):406-11. PubMed ID: 6504840
    [No Abstract]   [Full Text] [Related]  

  • 6. Ventilatory response to spironolactone in respiratory failure.
    Cochrane GM; Clark TJ
    Br J Dis Chest; 1972 Jan; 66(1):67-70. PubMed ID: 4552968
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of intravenous potassium canrenoate in patients with severe heart failure and digitalis toxicity.
    Cristodorescu R; Puschita M; Deutsch G; Berger E; Luca C
    Med Interne; 1977; 15(1):27-34. PubMed ID: 841250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative experimental and clinical studies of CT 1341 and hydroxydione].
    Benke A; Gogolák G; Stumpf C; Tschakaloff C
    Anaesthesist; 1972 Aug; 21(8):344-9. PubMed ID: 4403877
    [No Abstract]   [Full Text] [Related]  

  • 9. A fixed-dose combination of furosemide and spironolactone in digitalized congestive heart failure patients.
    Yasky J; Ledesma GA; Tutera A; Collia LF
    Pharmatherapeutica; 1986; 4(8):473-9. PubMed ID: 3714755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experiences with aldactone in pediatric cardiology (author's transl)].
    Wimmer M; Bachl G; Schlemmer M; Stiskal A
    Padiatr Padol; 1979; 14(4):363-72. PubMed ID: 530724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical studies on the acid-base balance disturbance in congestive heart failure.
    Awamura M
    Jpn Circ J; 1969 Mar; 33(3):275-91. PubMed ID: 5819413
    [No Abstract]   [Full Text] [Related]  

  • 12. The anti-dysrhythmic effect of Althesin.
    Cundy JM
    Anaesthesia; 1973 Sep; 28(5):544-5. PubMed ID: 4728159
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of a spironolactone, potassium canrenoate, on arrhythmia of the isolated auricle induced by a digitalic drug].
    Lamarche M; Royer R
    C R Seances Soc Biol Fil; 1971; 165(6):1432-3. PubMed ID: 4262058
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical amd metabolic results of a particular combination thiazide-antialdosterone in heart failure].
    Miraglia G; Nava A; Dalla Volta S
    Clin Ter; 1974 Mar; 68(5):445-51. PubMed ID: 4599565
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical investigations of the steroid anaesthetic agent CT-1341 (Althesin) (Cardiovascular and respiratory effects)].
    Rifat K; Stainier H; Gemperle M; Szappanyos G; Hemmer M; Weiss V
    Anaesthesist; 1975 Jan; 24(1):6-12. PubMed ID: 1093436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of successive use of aldactone and aldactacine in the management of congestive heart failure involving at the outset hypokalemia with or without cardiac rhythm disorders].
    Koate P; Diouf S; Sylla M; Diop G; Diop SN
    Dakar Med; 1981; 26(1):1-11. PubMed ID: 7238279
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic experience with osyrol 100/Lasix in the treatment of congestive heart failure (author's transl)].
    Freude J
    MMW Munch Med Wochenschr; 1979 Jun; 121(24):827-30. PubMed ID: 111084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of spironolactone and hydroflumethiazide alone and together in the treatment of hypertension.
    Jamil MA
    Guys Hosp Rep; 1971; 120(3):207-19. PubMed ID: 4951058
    [No Abstract]   [Full Text] [Related]  

  • 19. [Spironolactone in digitalis-requiring cardiac insufficiency following pacemaker implantation].
    Sabin G; Klüsener W
    Med Klin; 1981 Jan; 76(1):20-3. PubMed ID: 7254119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of the use of "Spirolang" 50].
    Gentili G; Liberti R
    Minerva Med; 1971 Feb; 62(17):816-27. PubMed ID: 5551769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.